These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 15568590)

  • 21. Infarct tissue heterogeneity assessed with contrast-enhanced MRI predicts spontaneous ventricular arrhythmia in patients with ischemic cardiomyopathy and implantable cardioverter-defibrillator.
    Roes SD; Borleffs CJ; van der Geest RJ; Westenberg JJ; Marsan NA; Kaandorp TA; Reiber JH; Zeppenfeld K; Lamb HJ; de Roos A; Schalij MJ; Bax JJ
    Circ Cardiovasc Imaging; 2009 May; 2(3):183-90. PubMed ID: 19808591
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Should patients with congenital heart disease and a systemic ventricular ejection fraction less than 30% undergo prophylactic implantation of an ICD? Patients with congenital heart disease and a systemic ventricular ejection fraction less than 30% should undergo prophylactic implantation of an implantable cardioverter defibrillator.
    Silka MJ; Bar-Cohen Y
    Circ Arrhythm Electrophysiol; 2008 Oct; 1(4):298-306. PubMed ID: 19808422
    [No Abstract]   [Full Text] [Related]  

  • 23. Selecting patients for an implantable cardioverter-defibrillator: can the genie be put back into the bottle?
    Mittal S
    J Am Coll Cardiol; 2008 Jan; 51(3):297-9. PubMed ID: 18206739
    [No Abstract]   [Full Text] [Related]  

  • 24. Impact of the main implantable cardioverter-defibrillator trials in clinical practice: data from the Italian ICD Registry for the years 2005-07.
    Proclemer A; Ghidina M; Gregori D; Facchin D; Rebellato L; Fioretti P; Brignole M
    Europace; 2009 Apr; 11(4):465-75. PubMed ID: 19136490
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Poor prognosis for patients with chronic kidney disease despite ICD therapy for the primary prevention of sudden death.
    Cuculich PS; Sánchez JM; Kerzner R; Greenberg SL; Sengupta J; Chen J; Faddis MN; Gleva MJ; Smith TW; Lindsay BD
    Pacing Clin Electrophysiol; 2007 Feb; 30(2):207-13. PubMed ID: 17338717
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [ICD-implantation--for which patients is its value for primary prevention secure?].
    Fiek M; Reithmann C; Steinbeck G
    Dtsch Med Wochenschr; 2006 Sep; 131(39):2165-8. PubMed ID: 16991035
    [No Abstract]   [Full Text] [Related]  

  • 27. Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction.
    Goldenberg I; Vyas AK; Hall WJ; Moss AJ; Wang H; He H; Zareba W; McNitt S; Andrews ML;
    J Am Coll Cardiol; 2008 Jan; 51(3):288-96. PubMed ID: 18206738
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prophylactic implantable cardioverter-defibrillator therapy in patients with left ventricular systolic dysfunction: a pooled analysis of 10 primary prevention trials.
    Nanthakumar K; Epstein AE; Kay GN; Plumb VJ; Lee DS
    J Am Coll Cardiol; 2004 Dec; 44(11):2166-72. PubMed ID: 15582314
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Italian Implantable Cardioverter-Defibrillator Registry. A survey of the national activity during the years 2001-2003.
    Proclemer A; Ghidina M; Cicuttini G; Gregori D; Fioretti PM
    Ital Heart J; 2005 Mar; 6(3):272-80. PubMed ID: 15875520
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy: clinical presentation, risk stratification and results of long-term follow-up.
    Pezawas T; Stix G; Kastner J; Schneider B; Wolzt M; Schmidinger H
    Int J Cardiol; 2006 Mar; 107(3):360-8. PubMed ID: 16503259
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relations among renal function, risk of sudden cardiac death, and benefit of the implanted cardiac defibrillator in patients with ischemic left ventricular dysfunction.
    Goldenberg I; Moss AJ; McNitt S; Zareba W; Andrews ML; Hall WJ; Greenberg H; Case RB;
    Am J Cardiol; 2006 Aug; 98(4):485-90. PubMed ID: 16893702
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Obesity as a risk factor for sustained ventricular tachyarrhythmias in MADIT II patients.
    Pietrasik G; Goldenberg I; McNitt S; Moss AJ; Zareba W
    J Cardiovasc Electrophysiol; 2007 Feb; 18(2):181-4. PubMed ID: 17338766
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Remarks on polyparametric assessment of sudden death risk for primary prevention ICD implantation in patients with left ventricular dysfunction of ischemic and non ischemic etiology. Italian Association of Hospital Cardiologists (ANMCO) Experts Position Paper].
    Disertori M; Gulizia MM; Casolo G; Delise P; Di Lenarda A; Di Tano G; Lunati M; Mestroni L; Salerno-Uriarte JA; Tavazzi L
    G Ital Cardiol (Rome); 2015 Nov; 16(11):651-66. PubMed ID: 26571481
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sudden death prophylaxis in heart failure.
    Rosanio S; Schwarz ER; Vitarelli A; Zarraga IG; Kunapuli S; Ware DL; Birnbaum Y; Tuero E; Uretsky BF
    Int J Cardiol; 2007 Jul; 119(3):291-6. PubMed ID: 17208319
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Revascularization versus implantable cardioverter-defibrillators to prevent sudden death in patients with severe left ventricular dysfunction.
    Weintraub WS
    Circulation; 2001 Sep; 104(13):1457-8. PubMed ID: 11571235
    [No Abstract]   [Full Text] [Related]  

  • 36. [Primary prevention of sudden death - afraid of the truth].
    Klein H
    Dtsch Med Wochenschr; 2002 Oct; 127(41):2113. PubMed ID: 12397556
    [No Abstract]   [Full Text] [Related]  

  • 37. Implantable cardioverter defibrillators and cardiac resynchronization therapy in patients with left ventricular dysfunction: randomized trial evidence through 2004.
    Al-Khatib SM; Sanders GD; Mark DB; Lee KL; Bardy GH; Bigger JT; Buxton AE; Connolly S; Kadish A; Moss A; Feldman AM; Ellenbogen KA; Singh S; Califf RM;
    Am Heart J; 2005 Jun; 149(6):1020-34. PubMed ID: 15976783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selecting patients for discussion of the ICD as primary prevention for sudden death in heart failure.
    Stevenson LW; Desai AS
    J Card Fail; 2006 Aug; 12(6):407-12. PubMed ID: 16911905
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary prevention of sudden cardiac death using implantable cardioverter defibrillators.
    Ding L; Hua W; Niu H; Chen K; Zhang S
    Europace; 2008 Sep; 10(9):1034-41. PubMed ID: 18559335
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prophylactic implantable cardioverter defibrillator therapy in dilated cardiomyopathy: impact of left ventricular function.
    Schaer BA; Ammann P; Sticherling C; Zellweger MJ; Cron TA; Osswald S
    Int J Cardiol; 2006 Mar; 108(1):26-30. PubMed ID: 16516695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.